Bone turnover 18 months after a single intravenous dose of zoledronic acid
Zoledronic acid inhibits bone resorption for up to 12 months. It is not known whether the duration of this antiresorptive effect extends beyond this period of time. The aim of this study was to evaluate the changes in bone turnover at 12 months (T12) and
|Collections||ANU Research Publications|
|Source:||International Journal of Clinical Practice|
|01_Borba_Bone_turnover_18_months_after_2007.pdf||179.52 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.